Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Survival Tree01:19

Survival Tree

125
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
125

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Phase II Trial of Perioperative Camrelizumab Plus Neoadjuvant Chemotherapy in Resectable Stage IIB-IIIB Lung Squamous Cell Carcinoma.

MedComm·2026
Same author

Analysis of Acquired Fusion Mutations in EGFR-TKIs-Resistant Patients with Advanced Lung Cancer.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2026
Same author

Real-world evidence for immunotherapy in the first-line or subsequent-line setting in extensive-stage small-cell lung cancer.

Therapeutic advances in medical oncology·2025
Same author

The characteristics and prognoses of 72 postoperative synchronous multiple primary lung cancer patients.

World journal of surgical oncology·2025
Same author

Pre-treatment Circulating Tumor Cell Associated White Blood Cell Clusters Independently Predict Poor Survival in Patients with Extensive-disease Small Cell Lung Cancer.

Biomarker insights·2025
Same author

The IASLC uncertain resection, general overview, current evidence, and future prospects: a systematic review and meta-analysis.

Therapeutic advances in medical oncology·2025

Related Experiment Video

Updated: Jul 29, 2025

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

150

Interpretable deep learning survival predictive tool for small cell lung cancer.

Dongrui Zhang1, Baohua Lu2, Bowen Liang3

  • 1Department of Respiratory and Critical Care Medicine, Tianjin Chest Hospital, Tianjin, China.

Frontiers in Oncology
|May 22, 2023
PubMed
Summary

Artificial intelligence deep learning offers new hope for predicting small cell lung cancer (SCLC) survival. A new AI model shows reliable prognostic value, aiding doctors and patients in treatment decisions.

Keywords:
clinical tooldeep learningneural networkpredictive modelsmall cell lung cancer

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K

Related Experiment Videos

Last Updated: Jul 29, 2025

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

150
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K

Area of Science:

  • Oncology
  • Bioinformatics
  • Artificial Intelligence

Background:

  • Small cell lung cancer (SCLC) is a highly aggressive and often fatal malignancy.
  • Current prognostic methods for SCLC lack accuracy.
  • Deep learning offers a potential advancement in predicting SCLC outcomes.

Purpose of the Study:

  • To develop and validate a deep learning survival model for predicting overall survival (OS) in patients with SCLC.
  • To create an accessible tool for clinicians, researchers, and patients.

Main Methods:

  • Utilized the Surveillance, Epidemiology, and End Results (SEER) database, including 21,093 SCLC patient records.
  • Developed a deep learning survival model using a training dataset (2010-2014) and validated it on a separate test dataset (2015).
  • Incorporated clinical features such as age, sex, tumor stage (TNM), tumor size, and treatment history; evaluated performance using the C-index.

Main Results:

  • The deep learning model achieved a C-index of 0.7181 in the training set and 0.7208 in the test set, indicating reliable predictive performance for OS in SCLC.
  • The validated model was developed into free Windows software for widespread use.

Conclusions:

  • An interpretable deep learning survival prediction tool for SCLC demonstrates reliable prognostic value for overall survival.
  • Further integration of biomarkers could enhance the predictive accuracy of SCLC prognostic models.